Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group

EU-Response investigators group

doi:10.1016/j.cmi.2021.10.011

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group

EU-Response investigators group

School of Medicine

ANRS
Institut national de la santé et de la recherche médicale
University of Oslo
ECRIN
Centro Hospitalar Universitário de São João
Université libre de Bruxelles
Hospices civils de Lyon
Hospital Universitario La Paz
Norwegian Institute of Public Health
University of Verona
Center Hospitalier de Luxembourg
Paracelsus Private Medical University
National and Kapodistrian University of Athens
University of Basel
Université Paris Cité
Sorbonne Université

Research output: Contribution to journal › Comment/Debate

Original language	English
Pages (from-to)	1-5
Number of pages	5
Journal	Clinical Microbiology and Infection
Volume	28
Issue number	1
DOIs	https://doi.org/10.1016/j.cmi.2021.10.011
Publication status	Published - Jan 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 10 Reduced Inequalities

Keywords

EU-RESPOSE
Financial hurdles
Legal hurdles
Platform trials
Regulatory hurdles

Access to Document

10.1016/j.cmi.2021.10.011

Cite this

@article{1ce3e4e436fc4a2094ec4085a35ba5c1,

title = "Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group",

keywords = "EU-RESPOSE, Financial hurdles, Legal hurdles, Platform trials, Regulatory hurdles",

author = "\{EU-Response investigators group\} and Alpha Diallo and Marius Tr{\o}seid and Simensen, \{Victoria Charlotte\} and Ana{\"i}s Boston and Jacques Demotes and Olsen, \{Inge Christoffer\} and Florence Chung and Paiva, \{Jos{\'e} Artur\} and Maya Hites and Florence Ader and Arribas, \{Jose Ramon\} and Andreas Baratt-Due and {\O}yvind Melien and Evelina Tacconelli and Th{\`e}r{\`e}se Staub and Richard Greil and Sotirios Tsiodras and Matthias Briel and H{\'e}l{\`e}ne Esperou and France Mentr{\'e} and Joe Eustace and Juliette Saillard and Christelle Delmas and Soizic LeMestre and Marina Dumousseaux and Dominique Costagliola and R{\o}ttingen, \{John Arne\} and Yazdan Yazdanpanah",

year = "2022",

month = jan,

doi = "10.1016/j.cmi.2021.10.011",

language = "English",

volume = "28",

pages = "1--5",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - Accelerating clinical trial implementation in the context of the COVID-19 pandemic

T2 - challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group

AU - EU-Response investigators group

AU - Diallo, Alpha

AU - Trøseid, Marius

AU - Simensen, Victoria Charlotte

AU - Boston, Anaïs

AU - Demotes, Jacques

AU - Olsen, Inge Christoffer

AU - Chung, Florence

AU - Paiva, José Artur

AU - Hites, Maya

AU - Ader, Florence

AU - Arribas, Jose Ramon

AU - Baratt-Due, Andreas

AU - Melien, Øyvind

AU - Tacconelli, Evelina

AU - Staub, Thèrèse

AU - Greil, Richard

AU - Tsiodras, Sotirios

AU - Briel, Matthias

AU - Esperou, Hélène

AU - Mentré, France

AU - Eustace, Joe

AU - Saillard, Juliette

AU - Delmas, Christelle

AU - LeMestre, Soizic

AU - Dumousseaux, Marina

AU - Costagliola, Dominique

AU - Røttingen, John Arne

AU - Yazdanpanah, Yazdan

PY - 2022/1

Y1 - 2022/1

KW - EU-RESPOSE

KW - Financial hurdles

KW - Legal hurdles

KW - Platform trials

KW - Regulatory hurdles

UR - https://www.scopus.com/pages/publications/85120439444

U2 - 10.1016/j.cmi.2021.10.011

DO - 10.1016/j.cmi.2021.10.011

M3 - Comment/Debate

C2 - 34763056

AN - SCOPUS:85120439444

SN - 1198-743X

VL - 28

SP - 1

EP - 5

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - 1

ER -

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group

UN SDGs

Keywords

Access to Document

Other files and links

Cite this